- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 20.7M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $57.2M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $50.93M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $271.36M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $281.91M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $525.36M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $526.55M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2.4M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 21.05M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $52K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $16.66M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.30 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.31 |
| Net Income | Q1 2025 · Mar 31, 2024 | $6.42M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $29.74M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $74.5M |